EGFR and ovarian carcinoma: Some of the genes involved in ovarian cancer development control the activation of specific intracellular signalling pathways, particularly PI3K/Akt, EGFR, HER2/neu, PKC1, Src, and Ras, that are activated in more than half of ovarian neoplasms and thus could represent future targets for new anticancer agents.